A New Era in Secondary Prevention after Acute Coronary Syndrome

A New Era in Secondary Prevention after Acute Coronary Syndrome: During the past two decades, the use of antiplatelet therapies has been the focus of new studies of secondary prevention after acute coronary syndromes, with more than 75% of patients in contemporary practice treated with dual antiplatelet therapy (aspirin plus a thienopyridine) on hospital…